The EIIAPA chimeric promoter for tumor specific gene therapy of hepatoma

Molecular Imaging and Biology

Volumn 14, Issue 4, 2012, Pages 452-461

  Hsieh, Ya Ju ^a,b   Chen, Fu Du ^c   Ke, Chien Chih ^b   Wang, Hsin Ell ^b   Huang, Chih Jen ^d   Hou, Ming Feng ^d   Lin, Kang Ping ^e   Gelovani, Juri G ^f   Liu, Ren Shyan ^b,c,g  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TRANSWORLD UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

124I FIAU; 131I FIAU; Bioluminescence imaging assay; Gene therapy; Hepatoma; Herpes simplex virus thymidine kinase; Luciferase gene; MicroPET

Indexed keywords

ALPHA FETOPROTEIN; FIALURIDINE I 124; FIALURIDINE I 131; GANCICLOVIR; LENTIVIRUS VECTOR; LUCIFERASE; LUCIFERIN; PLASMID VECTOR; RADIOPHARMACEUTICAL AGENT; THYMIDINE KINASE; UNCLASSIFIED DRUG;

ALPHA FETOPROTEIN GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLUMINESCENCE IMAGING; CANCER GENE THERAPY; CELL STRAIN HEPG2; CISTRON; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SPECIFICITY; GENE; GENE DIRECTED ENZYME PRODRUG THERAPY; GENE EXPRESSION; HEPATITIS B VIRUS ENHANCER II GENE; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MOLECULAR IMAGING; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TUMOR REGRESSION; TUMOR XENOGRAFT;

ALPHA-FETOPROTEINS; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL DEATH; CELL LINE, TUMOR; ENHANCER ELEMENTS, GENETIC; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; GANCICLOVIR; GENE EXPRESSION; GENETIC THERAPY; HEPATITIS B VIRUS; HUMANS; LENTIVIRUS; LIVER NEOPLASMS; LUCIFERASES; MALE; MICE; MICE, SCID; MOLECULAR IMAGING; NIH 3T3 CELLS; OPTICAL DEVICES; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

HEPATITIS B VIRUS; SIMPLEXVIRUS;

EID: 84865466292     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-011-0509-z     Document Type: Article

References (37)

1. Colombo M (1992) Hepatocellular carcinoma. J Hepatol 15:225-226
2. Venook AP (2000) Hepatocellular carcinoma. Curr Treat Options Oncol 1:407-415
3. Venook AP (1994) Treatment of hepatocellular carcinoma: too many options? J Clin Oncol 12:1323-1334 (Pubitemid 24173950)
4. Ren W, Strube R, Zhang X, Chen SY, Huang XF (2004) Potent tumorspecific immunity induced by an in vivo heat shock protein-suicide gene-based tumor vaccine. Cancer Res 64:6645-6651 (Pubitemid 39297925)
5. Stefani AL, Barzon L, Castagliuolo I, Guido M, Pacenti M, Parolin C, Farinati F, Palù G (2005) Systemic efficacy of combined suicide/cytokine gene therapy in a murine model of hepatocellular carcinoma. J Hepatol 42:728-735
6. Kang JH, Chung JK, Lee YJ, Shin JH, Jeong JM, Lee DS, Lee MC (2004) Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy. J Nucl Med 45:1571-1576
7. Gerolami R, Uch R, Faivre J, Garcia S, Hardwigsen J, Cardoso J, Mathieu S, Bagnis C, Brechot C, Mannoni P (2004) Herpes simplex virus thymidine kinase-mediated suicide gene therapy for hepatocellular carcinoma using HIV-1-derived lentiviral vectors. Hepatology 40:291-297 (Pubitemid 38115835)
8. Cao G, Kuriyama S, Gao J, Mitoro A, Cui L, Nagao S, Zhang X, Tsujinoue H, Pan X, Fukui H, Qi Z (1999) In vivo gene transfer of a suicide gene under the transcriptional control of the carcinoembryonic antigen promoter results in bone marrow transduction but can avoid bone marrow suppression. Int J Oncol 15:107-112
9. Herraiz M, Beraza N, Solano A, Sangro B, Montoya J, Qian C, Prieto J, Bustos M (2003) Liver failure caused by herpes simplex virus thymidine kinase plus ganciclovir therapy is associated with mitochondrial dysfunction and mitochondrial DNA depletion. Hum Gene Ther 14:463-472 (Pubitemid 36403538)
10. Jin YN, Chung HK, Kang JH, Lee YJ, Kimm KI, Kim YJ, Kim S, Chung JK (2008) Radioiodine gene therapy of hepatocellular carcinoma targeted human alpha fetoprotein. Cancer Biother Radiopharm 23:551-560
11. Ma XJ, Huang R, Kuang AR (2009) AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma. Cancer Invest 27:673-681
12. Qiao J, Doubrovin M, Sauter BV, Huang Y, Guo ZS, Balatoni J, Akhurst T, Blasberg RG, Tjuvajev JG, Chen SH, Woo SL (2002) Tumor-specific transcriptional targeting of suicide gene therapy. Gene Ther 9:168-175 (Pubitemid 34189576)
13. Iyer M, Salazar FB, Lewis X, Zhang L, Carey M, Wu L, Gambhir SS (2004) Noninvasive imaging of enhanced prostate-specific gene expression using a two-step transcriptional amplification-based lentivirus vector. Mol Ther 10:545-552 (Pubitemid 39186115)
14. Sato Y, Nakata K, Kato Y, Shima M, Ishii N, Koji T, Taketa K, Endo Y, Nagataki S (1993) Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. N Engl J Med 328:1802-1806 (Pubitemid 23174710)
15. Ido A, Nakata K, Kato Y, Nakao K, Murata K, Fujita M, Ishii N, Tamaoki T, Shiku H, Nagataki S (1995) Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter. Cancer Res 55:3105-3109
16. Dachs GU, Dougherty GJ, Stratford IJ, Chaplin DJ (1997) Targeting gene therapy to cancer: a review. Oncol Res 9:313-325 (Pubitemid 127825985)
17. Kanai F (2001) Transcriptional targeted gene therapy for hepatocellular carcinoma by adenovirus vector. Mol Biotechnol 18:243-250 (Pubitemid 32695286)
18. Kanai F, Shiratori Y, Yoshida Y, Wakimoto H, Hamada H, Kanegae Y, Saito I, Nakabayashi H, Tamaoki T, Tanaka T, Lan KH, Kato N, Shiina S, Omata M (1996) Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Hepatology 23:1359-1368 (Pubitemid 26181217)
19. Willhauck MJ, Sharif Samani BR, Klutz K, Cengic N, Wolf I, Mohr L, Geissler M, Senekowitsch-Schmidtke R, Göke B, Morris JC, Spitzweg C (2008) Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma. Gene Ther 15:214-223 (Pubitemid 351150044)
20. Ido A, Uto H, Moriuchi A, Nagata K, Onaga Y, Onaga M, Hori T, Hirono S, Hayashi K, Tamaoki T, Tsubouchi H (2001) Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter. Cancer Res 61:3016-3021 (Pubitemid 32691948)
21. Beasley RP, Hwang LY, Lin CC, Chien CS (1981) Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet 2:1129-1133
22. Szmuness W (1978) Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog Med Virol 24:40-69
23. Garcia AD, Ostapchuk P, Hearing P (1993) Functional interaction of nuclear factors EF-C, HNF-4, and RXR alpha with hepatitis B virus enhancer I. J Virol 67:3940-3950 (Pubitemid 23180718)
24. Trujillo MA, Letovsky J, Maguire HF, Lopez-Cabrera M, Siddiqui A (1991) Functional analysis of a liver-specific enhancer of the hepatitis B virus. Proc Natl Acad Sci USA 88:3797-3801 (Pubitemid 21916711)
25. Lopez-Cabrera M, Letovsky J, Hu KQ, Siddiqui A (1991) Transcriptional factor C/EBP binds to and transactivates the enhancer element II of the hepatitis B virus. Virology 183:825-829
26. Guo W, Chen M, Yen TS, Ou JH (1993) Hepatocyte-specific expression of the hepatitis B virus core promoter depends on both positive and negative regulation. Mol Cell Biol 13:443-448 (Pubitemid 23006922)
27. Yee JK (1989) A liver-specific enhancer in the core promoter region of human hepatitis B virus. Science 246:658-661
28. Su H, Yee JK (1992) Regulation of hepatitis B virus gene expression by its two enhancers. Proc Natl Acad Sci USA 89:2708-2712
29. Chen ST, La Porte P, Yee JK (1993) Mutational analysis of hepatitis B virus enhancer 2. Virology 196:652-659
30. Li J, Li H, Zhu L, Song W, Li R, Wang D, Dou K (2010) The adenovirus-mediated linamarase/linamarin suicide system: a potential strategy for the treatment of hepatocellular carcinoma. Cancer Lett 289:217-227
31. Liu F, Wang P, Jiang X, Tan G, Qiao H, Jiang H, Krissansen GW, Sun X (2008) Antisense hypoxia-inducible factor 1alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma. Cancer Sci 99:2055-2061
32. Chen G, Wang Y, Zhou M, Shi H, Yu Z, Zhu Y, Yu F (2010) EphA1 receptor silencing by small interfering RNA has antiangiogenic and antitumor efficacy in hepatocellular carcinoma. Oncol Rep 23:563-570
33. Ishikawa H, Nakata K, Mawatari F, Ueki T, Tsuruta S, Ido A, Nakao K, Kato Y, Ishii N, Eguchi K (1999) Utilization of variant-type of human alpha-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma. Gene Ther 6:465-470 (Pubitemid 29192655)
34. Galarneau L, Pare JF, Allard D, Hamel D, Levesque L, Tugwood JD, Green S, Bélanger L (1996) The alpha1-fetoprotein locus is activated by a nuclear receptor of the Drosophila FTZ-F1 family. Mol Cell Biol 16:3853-3865 (Pubitemid 26199905)
35. Gilbert S, Galarneau L, Lamontagne A, Roy S, Bélanger L (2000) The hepatitis B virus core promoter is strongly activated by the liver nuclear receptor fetoprotein transcription factor or by ectopically expressed steroidogenic factor 1. J Virol 74:5032-5039 (Pubitemid 30313842)
36. Ishida H, Ueda K, Ohkawa K, Kanazawa Y, Hosui A, Nakanishi F, Mita E, Kasahara A, Sasaki Y, Hori M, Hayashi N (2000) Identification of multiple transcription factors, HLF, FTF, and E4BP4, controlling hepatitis B virus enhancer II. J Virol 74:1241-1251 (Pubitemid 30044073)
37. Xu L, Hui L, Wang S, Gong J, Jin Y, Wang Y, Ji Y, Wu X, Han Z, Hu G (2001) Expression profiling suggested a regulatory role of liverenriched transcription factors in human hepatocellular carcinoma. Cancer Res 61:3176-3181 (Pubitemid 32691972)